LinkDoc, a Beijing Cancer Data Company, to Raise up to $500 Million in US IPO
publication date: Jun 15, 2021
Beijing's LinkDoc Technology, an AI driven healthcare company based on cancer patient data, filed to IPO on the NASDAQ exchange. LinkDoc has been supported by Alibaba. The company structures cancer patient data, which it acquires from 330 top tier China hospitals, to support precision medicine and personalized care. So far, it has longitudinal data on 2.5 million oncology patients and has helped 3.5 million patients. During its most recent 12 months, LinkDoc booked $157 million in revenue and claims to have the largest China market share in its field. LinkDoc may be seeking to raise as much as $500 million. More details....
Share this with colleagues:
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.